We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Guidant will lay off an unspecified number of employees in its coronary stent unit in an effort to shore up the firm’s financial security and sustain its two drug-eluting stent programs.
Strong intellectual property protections in the new U.S. free trade deal with Morocco will encourage brand pharmaceutical firms to invest in the North African country and lead to a stronger generic drug industry there, according to U.S. trade officials.
The House has passed legislation that would require companies to expense the stock options of only the five highest-paid company executives — a move praised by the biotechnology industry, which had opposed another government proposal requiring companies to expense all employee stock options.
President Bush signed legislation yesterday that authorizes Congress to appropriate $5.6 billion over the next 10 years for the federal government to develop and stockpile drugs, vaccines and other antidotes in the event of terrorist attacks using weapons of mass destruction.
As the generic drug industry urges the FDA and Congress to develop an approval pathway for generic biologics, some firms already are marketing the products.
A new study has found that despite extensive efforts by the government and the AARP, support among Medicare beneficiaries for the new prescription drug program is flagging.
The New England Journal of Medicine was one of four scholarly publications that published research articles by contributing authors who did not disclose potential conflicts of interest, according to a study released this week.
Extensive efforts by the government and the AARP to garner support among Medicare beneficiaries for the new prescription drug program have failed to engage eligible seniors, according to a new study.
A pilot program launched by the FDA and the Global Harmonization Task Force (GHTF) to provide a streamlined alternative to the complex process of international premarket filings has been extended for a second year, according to a July 8 Federal Register notice.
Pfizer company said last week it will offer its prescription medications to the estimated 43 million Americans without insurance at significant discounts or for free.